Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55.5M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
45.6M
-
Shares change
-
+3.71M
-
Total reported value, excl. options
-
$1.4B
-
Value change
-
+$114M
-
Put/Call ratio
-
1.54
-
Number of buys
-
59
-
Number of sells
-
-63
-
Price
-
$30.81
Significant Holders of Arcellx, Inc. - COMMON STOCK (ACLX) as of Q1 2023
140 filings reported holding ACLX - Arcellx, Inc. - COMMON STOCK as of Q1 2023.
Arcellx, Inc. - COMMON STOCK (ACLX) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.6M shares
of 55.5M outstanding shares and own 82.09% of the company stock.
Largest 10 shareholders include SR ONE CAPITAL MANAGEMENT, LP (5.5M shares), NEA Management Company, LLC (4.75M shares), PERCEPTIVE ADVISORS LLC (3.84M shares), FMR LLC (2.68M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.4M shares), BlackRock Inc. (2.22M shares), STATE STREET CORP (1.87M shares), Paradigm Biocapital Advisors LP (1.76M shares), Cormorant Asset Management, LP (1.6M shares), and JANUS HENDERSON GROUP PLC (1.59M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.